MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells

Show simple item record

dc.contributor.author Gomez Zubieta, Daniela M
dc.contributor.author Hamood, Mohamed A
dc.contributor.author Beydoun, Rami
dc.contributor.author Pall, Ashley E
dc.contributor.author Kondapalli, Kalyan C
dc.date.accessioned 2017-12-24T04:17:05Z
dc.date.available 2017-12-24T04:17:05Z
dc.date.issued 2017-12-21
dc.identifier.citation Cell Communication and Signaling. 2017 Dec 21;15(1):55
dc.identifier.uri http://dx.doi.org/10.1186/s12964-017-0209-7
dc.identifier.uri http://hdl.handle.net/2027.42/140393
dc.description.abstract Abstract Background Glioblastoma multiformae (GBM) is the most aggressive type of malignant brain tumor with complex molecular profile. Overexpression of Na+/H+ Exchanger isoform 9 (NHE9) promotes tumor progression and correlates positively with insensitivity to radiochemotherapy and poor prognosis. However, molecular mechanisms responsible for increase in NHE9 levels beyond a critical threshold have not been identified. Methods Bioinformatics analysis, luciferase reporter assays, real-time PCR and western blotting were conducted to examine the expression profiles and identify microRNAs (miRNA) that target NHE9. Cell proliferation and migration assays were conducted in U87 glioblastoma cells to determine the consequence of miRNA mediated targeting of NHE9. Endosomal pH measurements, immunofluorescence microscopy and surface biotinylation experiments were conducted to characterize the mechanistic basis of regulation. Results We show that microRNA 135a (miR-135a) targets NHE9 to downregulate its expression in U87 cells. MiR-135a levels are significantly lower in glioblastoma cells compared to normal brain tissue. Downregulation of NHE9 expression by miR-135a affects proliferative and migratory capacity of U87 cells. Selectively increasing NHE9 expression in these cells restored their ability to proliferate and migrate. We demonstrate that miR-135a takes a two-pronged approach affecting epidermal growth factor receptors (EGFRs) to suppress tumor cell growth and migration. EGFR activity is a potent stimulator of oncogenic signaling. While miR-135a targets EGFR transcripts to decrease the total number of receptors made, by targeting NHE9 it routes the few EGFRs made away from the plasma membrane to dampen oncogenic signaling. NHE9 is localized to sorting endosomes in glioblastoma cells where it alkalinizes the endosome lumen by leaking protons. Downregulation of NHE9 expression by miR-135a acidifies sorting endosomes limiting EGFR trafficking to the glioblastoma cell membrane. Conclusions We propose downregulation of miR-135a as a potential mechanism underlying the high NHE9 expression observed in subset of glioblastomas. Future studies should explore miR-135a as a potential therapeutic for glioblastomas with NHE9 overexpression.
dc.title MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells
dc.type Journal Article
dc.description.bitstreamurl https://deepblue.lib.umich.edu/bitstream/2027.42/140393/1/12964_2017_Article_209.pdf
dc.language.rfc3066 en
dc.rights.holder The Author(s).
dc.date.updated 2017-12-24T04:17:07Z
dc.owningcollname Interdisciplinary and Peer-Reviewed
 Show simple item record

This item appears in the following Collection(s)

Search Deep Blue

Advanced Search

Browse by

My Account


Coming Soon

MLibrary logo